Urinary Inositol Phosphoglycan P-Type as A Marker for Prediction of Preeclampsia and Novel Implications for the Pathophysiology of This Disorder

REFERENCES

• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365:785–799.
   PubMed Web of Science ®Google Scholar
• Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996; 175:1365–1370.
   PubMed Web of Science ®Google Scholar
• Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1–S22.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102:181–192.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004; 104:1367–1391.
   PubMed Web of Science ®Google Scholar
• Kunjara S, Greenbaum AL, Wang DY, . Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Mol Genet Metab 2000; 69:144–158.
   PubMed Web of Science ®Google Scholar
• Paine MA, Scioscia M, Gumaa KA, Rodeck CH, Rademacher TW. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia. J Reprod Immunol 2006; 69:165–179.
   PubMed Web of Science ®Google Scholar
• Rademacher TW, Caro H, Kunjara S, Wang DY, Greenbaum AL, McLean P. Inositolphosphoglycan second messengers. Braz J Med Biol Res 1994; 27:327–341.
   Google Scholar
• Scioscia M, Gumaa K, Whitten M, Selvaggi LE, Rodeck CH, Rademacher TW. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies. J Reprod Immunol 2007; 76:85–90.
   Google Scholar
• Rademacher TW, Gumaa K, Scioscia M. Preeclampsia, insulin signalling and immunological dysfunction: A fetal, maternal or placental disorder? J Reprod Immunol 2007; 76:78–94.
   Google Scholar
• Williams PJ, Gumaa K, Scioscia M, Redman CW, Rademacher TW. Inositol phosphoglycan P-type in preeclampsia: a novel marker? Hypertension 2007; 49:84–89.
   PubMed Web of Science ®Google Scholar
• Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330: 565.
   PubMed Web of Science ®Google Scholar
• Varela-Nieto I, Leon Y, Caro HN. Cell signalling by inositol phosphoglycans from different species. Comp Biochem Physiol B Biochem Mol Biol 1996; 115:223–241.
   PubMedGoogle Scholar
• Barton JR, Istwan NB, Rhea D, Collins A, Stanziano GJ. Cost-savings analysis of an outpatient management program for women with pregnancy-related hypertensive conditions. Dis Manag 2006; 9:236–241.
   PubMedGoogle Scholar
• Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002; 359:881–884.
   PubMed Web of Science ®Google Scholar
• Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005; 365:1500–1505.
   PubMed Web of Science ®Google Scholar
• Paine MA, Rodeck CH, Williams PJ, Rademacher TW. Possible involvement of inositol phosphoglycan-P in human parturition. J Reprod Immunol 2003; 59:267–275.
   PubMedGoogle Scholar
• Myatt L, Miodovnik M. Prediction of preeclampsia. Semin Perinatol 1999; 23:45–57.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1592–1594.
   PubMed Web of Science ®Google Scholar
• Robillard PY, Hulsey TC. Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception. Lancet 1996; 347:619.
   PubMedGoogle Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448–454.
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116:1793–1801.
   PubMed Web of Science ®Google Scholar
• Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 1999; 48:892–896.
   PubMed Web of Science ®Google Scholar
• Martinez AE, Gonzalez OM, Quinones GA, Ferrannini E. Hyperinsulinemia in glucose-tolerant women with preeclampsia. A controlled study. Am J Hypertens 1996; 9:610–614.
   Google Scholar
• Scioscia M, Gumaa K, Kunjara S . Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J Clin Endocrinol Metab 2006; 91:709–717.
   PubMedGoogle Scholar
• Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59:161–173.
   PubMed Web of Science ®Google Scholar
• Scioscia M, Vimercati A, Selvaggi LE, Rodeck CH, Rademacher TW. Inositol phosphoglycan putative insulin mediator in human amniotic fluid. J Matern Fetal Neonatal Med 2006; 19:9–12.
   PubMed Web of Science ®Google Scholar
• Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113:1888–1904.
   PubMed Web of Science ®Google Scholar
• Cywinski J. The essentials in pressure monitoring. Martinus Nijhoff Publishers: Boston, 1980; 23–24.
   Google Scholar